Cellex Cell Professionals

Executive Summary

Cellex Cell Professionals is a German-based CDMO specializing in contract development and manufacturing of cell and gene therapies, with a proven track record of supporting three approved CAR-T therapies. Founded in 2003 in Cologne, the company offers full-service support from preclinical development through commercial GMP-compliant production for both autologous and allogeneic therapies. Its deep expertise and regulatory experience position it as a key partner for biotech and pharma companies advancing cell therapies. As the cell therapy market expands, Cellex stands to benefit from increasing outsourcing demand, given its established infrastructure and quality credentials. However, as a private company, its financial transparency is limited, and growth depends on securing new client partnerships and expanding capacity.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new multi-year manufacturing agreement with a major pharma or biotech company70% success
• Q4 2026Regulatory approval of a cell therapy produced at Cellex facilities (e.g., from a client's pipeline)50% success
• 2026-12-31Initiation of expansion of manufacturing capacity or new facility construction60% success